Xeris Biopharma Holdings, Inc. XERS Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s net income?
- Xeris Biopharma Holdings, Inc. (XERS) reported net income of $2.23M in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s net income changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s net income increased by 124.2% year-over-year, from -$9.22M to $2.23M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s net income?
- Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s net income has grown at a -74.1% compound annual growth rate (CAGR), from -$122.73M to $554K.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.